APA

Stemmler J., Stieber P., Szymala A. M., Schalhorn A., Schermuly M. M., Wilkowski R., Helmberger T., Lamerz R., Stoffregen C., Niebler K., Garbrecht M. & Heinemann V. (20040308). Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?. : Onkologie.

Chicago

Stemmler J, Stieber P, Szymala A M, Schalhorn A, Schermuly M M, Wilkowski R, Helmberger T, Lamerz R, Stoffregen C, Niebler K, Garbrecht M and Heinemann V. 20040308. Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?. : Onkologie.

Harvard

Stemmler J., Stieber P., Szymala A. M., Schalhorn A., Schermuly M. M., Wilkowski R., Helmberger T., Lamerz R., Stoffregen C., Niebler K., Garbrecht M. and Heinemann V. (20040308). Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?. : Onkologie.

MLA

Stemmler J, Stieber P, Szymala A M, Schalhorn A, Schermuly M M, Wilkowski R, Helmberger T, Lamerz R, Stoffregen C, Niebler K, Garbrecht M and Heinemann V. Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?. : Onkologie. 20040308.